The Lynx Group

AVBCC 2016

Washington, DC—With tremendous changes occurring in healthcare and particularly in oncology, discussion about the current trends and demands facing stakeholders in optimizing value in cancer care dominated the Sixth Annual Conference of the Association for Value-Based Cancer Care, held September 27-29, 2016, and co-chaired by Michael Kolodziej, MD, National Medical Director, Managed Care Strategy, Flatiron Health, New York, NY; and Burt Zweigenhaft, BS, President, National Association of Specialty Pharmacy; and Editor-in-Chief, Value-Based Cancer Care.
Read Article

Witnessing the Exciting Changes Within Cancer Care
Michael Kolodziej, MD, talks about some of the newer aspects of the cancer clinical care field including personalized medicine, immunotherapy, as well as how we plan to pay for cancer care.
Read Article

Looking at Cancer Care Trends
Michael Kolodziej, MD, talks about the various types of therapies as well as other elements such as the comprehensive care delivery model, the total cost of care, and the best way to personalize care as the topics that are driving the market today.
Read Article

Data's Increasing Role in Clinical Care
Michael Kolodziej, MD,  predicts that the greater proliferation of technology, specifically as used as a means for data collection, will have a vital role in patient treatments as well as understanding what the personalized care delivery approach should be.
Read Article

The Disconnect Between Health Care Providers and Payers
Michael Kolodziej, MD, speaks to the issue of how clinical oncologists lack an understanding of how payers operate, but that payers can help create a "roadmap" to success for the oncologists when it comes to the evolving model of care.
Read Article

The Broad Perspective
Michael Kolodziej, MD, points out the large number of key opinion leaders from different industries within health care who come together at the conference, and how that helps to create a well-balanced larger perspective when taking on the subject of value-based cancer care.
Read Article

Changes in Cancer Care
Gary Palmer, MD, JD, MBA, MPH points out how a better overall understanding of genomics and the immune system have had in developing oncology therapies.
Read Article

The Use of Genomics in Cancer Care
Gary Palmer, MD, JD, MBA, MPH discusses some of the ways in which this branch of molecular biology is used in developing cancer therapies.
Read Article

Understanding the Cancer Moonshot
Gary Palmer, MD, JD, MBA, MPH provides an overview of this significant federal initiative.
Read Article

The Advantages of Attending Industry Meetings
Gary Palmer, MD, JD, MBA, MPH offers some benefits to attending conferences such as AVBCC.
Read Article

Page 1 of 2

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to recieve the free VBCC print publication or weekly e‑Newsletter.

I'd like to recieve: